2025
SJR Q1
JCR Q1 · 18
8 eşleşen makale
SCIE
Dergi ayrıntısı
Circulation Research
- Yayıncı
- Lippincott Williams and Wilkins
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
0009733015244571
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 5,371
- Quartile Q1
- H-Index 420
- Atıf/yayın 12,32
- Doküman (3y) 726
- Atıf (3y) 10.175
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 18
- 5Y JIF 23
- JCI 4,06
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Cardiology and Cardiovascular Medicine Q1
- Physiology Q1
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS kategorileri
- Cardiac & Cardiovascular System | Hematology | Peripheral Vascular Diseases
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 5,371 | 18 | 23 | 4,06 | Q1 | 420 |
| 2024 | Q1 | Q1 | 4,897 | 16,2 | 20,8 | 4,13 | Q1 | 402 |
| 2023 | Q1 | Q1 | 4,903 | 16,5 | 20,3 | 4,22 | Q1 | 402 |
| 2022 | Q1 | Q1 | 4,531 | 20,1 | 22,4 | 3,93 | Q1 | 402 |
| 2021 | Q1 | Q1 | 4,709 | 23,2 | 25,2 | 3,81 | Q1 | 402 |
| 2020 | Q1 | Q1 | 4,899 | 17,4 | 20,8 | 3,54 | Q1 | 402 |
| 2019 | Q1 | Q1 | 4,685 | 14,5 | 15,6 | 3,63 | Q1 | 402 |
| 2018 | — | Q1 | — | 15,9 | 14,6 | 3,75 | Q1 | — |
| 2017 | Q1 | Q1 | 6,813 | 15,2 | 13,3 | 3,5 | Q1 | 402 |
| 2016 | Q1 | Q1 | 6,005 | 14 | 12 | — | — | 402 |
| 2015 | Q1 | Q1 | 5,908 | 11,6 | 11,2 | — | — | 402 |
| 2014 | Q1 | Q1 | 5,629 | 11 | 11 | — | — | 402 |
| 2013 | Q1 | Q1 | 6,385 | 11,1 | 10,8 | — | — | 402 |
| 2012 | Q1 | Q1 | 5,913 | 11,9 | 11 | — | — | 402 |
| 2011 | Q1 | Q1 | 5,616 | 9,5 | 10 | — | — | 402 |
| 2010 | Q1 | Q1 | 5,615 | 9,5 | 10,2 | — | — | 402 |
| 2009 | — | Q1 | — | 9,2 | 9,9 | — | — | — |
| 2008 | — | Q1 | — | 10 | 10,4 | — | — | — |
| 2007 | — | Q1 | — | 9,7 | 10,6 | — | — | — |
| 2006 | — | Q1 | — | 9,9 | — | — | — | — |
| 2005 | — | Q1 | — | 9,4 | — | — | — | — |
| 2004 | — | Q1 | — | 10 | — | — | — | — |
| 2003 | — | Q1 | — | 10,1 | — | — | — | — |
| 2002 | — | Q1 | — | 9,7 | — | — | — | — |
| 2001 | — | Q1 | — | 9,2 | — | — | — | — |
| 2000 | — | Q1 | — | 9,2 | — | — | — | — |
| 1999 | — | Q1 | — | 8,3 | — | — | — | — |
| 1998 | — | Q1 | — | 8 | — | — | — | — |
| 1997 | — | Q1 | — | 8,4 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | Q1 | 6/237 |
| 2025 | HEMATOLOGY | SCIE | Q1 | Q1 | 4/103 |
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 2/100 |
| 2024 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | Q1 | 5/231 |
| 2024 | HEMATOLOGY | SCIE | Q1 | Q1 | 4/99 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 2/98 |
| 2023 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | Q1 | 6/222 |
| 2023 | HEMATOLOGY | SCIE | Q1 | Q1 | 3/97 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 2/96 |
| 2022 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | Q1 | 6/143 |
| 2022 | HEMATOLOGY | SCIE | Q1 | Q1 | 4/79 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 2/68 |
| 2021 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | Q1 | 6/143 |
| 2021 | HEMATOLOGY | SCIE | Q1 | Q1 | 3/78 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 2/67 |
| 2020 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | Q1 | 5/142 |
| 2020 | HEMATOLOGY | SCIE | Q1 | Q1 | 4/76 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 2/65 |
| 2019 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | Q1 | 5/138 |
| 2019 | HEMATOLOGY | SCIE | Q1 | Q1 | 2/76 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 2/65 |
| 2018 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | Q1 | 5/136 |
| 2018 | HEMATOLOGY | SCIE | Q1 | Q1 | 2/73 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 2/65 |
| 2017 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | Q1 | 4/128 |
| 2017 | HEMATOLOGY | SCIE | Q1 | Q1 | 1/71 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 2/65 |
| 2016 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 5/126 |
| 2016 | HEMATOLOGY | SCIE | Q1 | — | 1/70 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/63 |
| 2015 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 4/124 |
| 2015 | HEMATOLOGY | SCIE | Q1 | — | 3/70 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/63 |
| 2014 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 4/123 |
| 2014 | HEMATOLOGY | SCIE | Q1 | — | 1/68 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/60 |
| 2013 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 4/125 |
| 2013 | HEMATOLOGY | SCIE | Q1 | — | 1/68 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/65 |
| 2012 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 4/124 |
| 2012 | HEMATOLOGY | SCIE | Q1 | — | 1/67 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/68 |
| 2011 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 4/117 |
| 2011 | HEMATOLOGY | SCIE | Q1 | — | 4/68 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/68 |
| 2010 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 4/114 |
| 2010 | HEMATOLOGY | SCIE | Q1 | — | 3/66 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/68 |
| 2009 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 4/95 |
| 2009 | HEMATOLOGY | SCIE | Q1 | — | 3/61 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/61 |
| 2008 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 3/79 |
| 2008 | HEMATOLOGY | SCIE | Q1 | — | 3/62 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/56 |
| 2007 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 3/75 |
| 2007 | HEMATOLOGY | SCIE | Q1 | — | 3/63 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/54 |
| 2006 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 2/74 |
| 2006 | HEMATOLOGY | SCIE | Q1 | — | 3/61 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/52 |
| 2005 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 2/72 |
| 2005 | HEMATOLOGY | SCIE | Q1 | — | 3/60 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/51 |
| 2004 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 2/71 |
| 2004 | HEMATOLOGY | SCIE | Q1 | — | 2/62 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/51 |
| 2003 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 2/70 |
| 2003 | HEMATOLOGY | SCIE | Q1 | — | 3/62 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/52 |
| 2002 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 2/66 |
| 2002 | HEMATOLOGY | SCIE | Q1 | — | 2/61 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/52 |
| 2001 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 2/65 |
| 2001 | HEMATOLOGY | SCIE | Q1 | — | 3/59 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 3/50 |
| 2000 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 2/63 |
| 2000 | HEMATOLOGY | SCIE | Q1 | — | 2/60 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/45 |
| 1999 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 2/67 |
| 1999 | HEMATOLOGY | SCIE | Q1 | — | 3/60 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/44 |
| 1998 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 2/62 |
| 1998 | HEMATOLOGY | SCIE | Q1 | — | 3/59 |
| 1998 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/39 |
| 1997 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q1 | — | 2/62 |
| 1997 | HEMATOLOGY | SCIE | Q1 | — | 3/59 |
| 1997 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 2/38 |